Today Eli Lilly & Co. offered guidance for 2016 that was below current FactSet consensus levels. Eli Lilly said it expects revenue to range from $20.2 billion to $20.7 billion for the year, and adjusted per-share earnings to range from $3.45 to $3.55. The FactSet consensus is for EPS of $3.65 and revenue of $21.6 billion. The company reiterated its outlook for adjusted 2015 EPS of $3.40 to $3.45, compared with the FactSet consensus of $3.44. I think stocks of the company may fall today.